Stroke

Showing NaN - NaN of 85

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stroke, Aortic Valve Stenosis, Silent Cerebral Infarct Trial in London (CO2 and saline flushing, Saline flushing)

Recruiting
  • Stroke
  • +3 more
  • CO2 and saline flushing
  • Saline flushing
  • London, United Kingdom
    Imperial College London
Nov 23, 2021

Stroke, Stroke, Ischemic, Stroke Hemorrhagic Trial in Canada (Telerehabilitation)

Completed
  • Stroke
  • +10 more
  • Telerehabilitation
  • Vancouver, British Columbia, Canada
  • +4 more
Nov 5, 2021

Atrial Fibrillation, Stroke Trial in Worldwide (Apixaban, aspirin)

Active, not recruiting
  • Atrial Fibrillation
  • Stroke
  • Mesa, Arizona
  • +129 more
Aug 25, 2021

Atrial Fibrillation, Stroke Trial in Paris, London

Completed
  • Atrial Fibrillation
  • Stroke
    • Paris, France
    • +1 more
    May 4, 2021

    GLORIA-AF Registry Program - Second and Third Phases

    Completed
    • Stroke
    • Atrial Fibrillation
      • Mobile, Alabama
      • +665 more
      Mar 3, 2021

      Aphasia, Stroke, Language Disorders Trial in London (Language treatment for improving discourse production, Transcranial

      Completed
      • Aphasia
      • +2 more
      • Language treatment for improving discourse production
      • Transcranial direct-current stimulation (tDCS)
      • London, United Kingdom
        King's College London
      Feb 17, 2021

      Carotid Stenosis, Atherosclerosis, Stroke Trial in Germany, United Kingdom (Revacept, Placebo)

      Completed
      • Carotid Stenosis
      • +5 more
      • Munich, Bavaria, Germany
      • +11 more
      Jan 27, 2021

      GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

      Completed
      • Stroke
      • Atrial Fibrillation
        • Bad Pirawarth, Austria
        • +522 more
        Dec 7, 2020

        Fatigue, Stroke Trial in London (Anodal tDCS, sham tDCS)

        Completed
        • Fatigue
        • Stroke
        • Anodal tDCS
        • sham tDCS
        • London, United Kingdom
          33 Queen Square, Institute of Neurology, UCL
        Nov 17, 2020

        Stroke Trial in London (Reading Training)

        Active, not recruiting
        • Stroke
        • Reading Training
        • London, United Kingdom
          The Wellington Hospital
        Nov 2, 2020

        Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

        Completed
        • Stroke
        • +2 more
        • Birmingham, Alabama
        • +182 more
        Apr 14, 2020

        Language Disorders, Aphasia, Stroke Trial in London (Transcranial direct-current stimulation (tDCS))

        Completed
        • Language Disorders
        • +2 more
        • Transcranial direct-current stimulation (tDCS)
        • London, United Kingdom
          King's College London
        Feb 7, 2020

        Aphasia, Stroke Trial in London (Adapted Solution Focused Brief Therapy)

        Completed
        • Aphasia
        • Stroke
        • Adapted Solution Focused Brief Therapy
        • London, United Kingdom
          City, University of London
        Feb 7, 2020

        Stroke Trial in London (Cognitive therapy)

        Completed
        • Stroke
        • Cognitive therapy
        • London, United Kingdom
          University College London, Research Dept of Language and Cogniti
        Jan 27, 2020

        Stroke, Hemispatial Neglect Trial in London (Guanfacine, Placebo)

        Completed
        • Stroke
        • Hemispatial Neglect
        • London, United Kingdom
          Imperial College Healthcare NHS Trust
        Jan 6, 2020

        Atrial Fibrillation, Thromboembolism, Stroke Trial in Worldwide (Subjects implanted with Amulet Device)

        Completed
        • Atrial Fibrillation
        • +2 more
        • Subjects implanted with Amulet Device
        • Murdoch, Western Australia, Australia
        • +50 more
        Dec 11, 2019

        Post Trial Follow-Up Study

        Completed
        • Hypertension
        • +4 more
          • London, United Kingdom
            International Centre for Circulatory Health
          Nov 13, 2019

          The Ontario Neurodegenerative Disease Research Initiative

          Completed
          • Alzheimer Disease
          • +4 more
          • Observational Cohort
          • Hamilton, Ontario, Canada
          • +11 more
          Sep 23, 2019

          Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)

          Completed
          • Stroke
          • Secondary Prevention
          • optional ASA as comedication
          • +5 more
          • Phoenix, Arizona
          • +568 more
          Aug 13, 2019

          Total Cerebral Protection With Embolic Protection Devices

          Suspended
          • Stroke
          • Silent Cerebral Infarct
          • Sentinel and Spider
          • London, United Kingdom
            St Mary's Hospital
          Aug 20, 2019

          Cardiovascular Diseases

          Completed
          • Stroke
          • +3 more
            • London, United Kingdom
              Imperial College London
            Jun 11, 2019

            Stroke, Silent Cerebral Infarction, Neurocognitive Dysfunction Trial in London (CO2 flushing, Saline flushing)

            Unknown status
            • Stroke
            • +3 more
            • CO2 flushing
            • Saline flushing
            • London, United Kingdom
              Imperial College London
            May 8, 2019

            Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)

            Completed
            • Atrial Fibrillation
            • Stroke
            • Birmingham, Alabama
            • +983 more
            Apr 8, 2019

            Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban

            Completed
            • Stroke
            • +2 more
            • warfarin tablets
            • +4 more
            • Birmingham, Alabama
            • +1015 more
            Feb 8, 2019

            Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

            Terminated
            • Stroke
            • Rivaroxaban (Xarelto, BAY59-7939)
            • +3 more
            • Tucson, Arizona
            • +453 more
            Dec 20, 2018